nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CA6—saliva—nicotine dependence	0.116	0.446	CbGeAlD
Brinzolamide—Upper-airway cough syndrome—Varenicline—nicotine dependence	0.0633	0.0856	CcSEcCtD
Brinzolamide—Depressed mood—Varenicline—nicotine dependence	0.0259	0.035	CcSEcCtD
Brinzolamide—Sinus congestion—Varenicline—nicotine dependence	0.0232	0.0314	CcSEcCtD
Brinzolamide—Throat irritation—Varenicline—nicotine dependence	0.0229	0.031	CcSEcCtD
Brinzolamide—CA7—midbrain—nicotine dependence	0.0189	0.0726	CbGeAlD
Brinzolamide—Upset stomach—Varenicline—nicotine dependence	0.0177	0.0239	CcSEcCtD
Brinzolamide—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.0171	0.0232	CcSEcCtD
Brinzolamide—Laryngeal pain—Varenicline—nicotine dependence	0.017	0.0229	CcSEcCtD
Brinzolamide—CA14—midbrain—nicotine dependence	0.0157	0.0605	CbGeAlD
Brinzolamide—Rhinorrhoea—Varenicline—nicotine dependence	0.0143	0.0193	CcSEcCtD
Brinzolamide—CA5B—cardiovascular system—nicotine dependence	0.0141	0.0542	CbGeAlD
Brinzolamide—Eye irritation—Varenicline—nicotine dependence	0.0135	0.0183	CcSEcCtD
Brinzolamide—Chest discomfort—Varenicline—nicotine dependence	0.0131	0.0177	CcSEcCtD
Brinzolamide—Lacrimation increased—Varenicline—nicotine dependence	0.0126	0.017	CcSEcCtD
Brinzolamide—CA1—cardiovascular system—nicotine dependence	0.0124	0.0478	CbGeAlD
Brinzolamide—CA7—brain—nicotine dependence	0.0118	0.0456	CbGeAlD
Brinzolamide—Blood pressure increased—Varenicline—nicotine dependence	0.0116	0.0156	CcSEcCtD
Brinzolamide—Nightmare—Varenicline—nicotine dependence	0.0112	0.0151	CcSEcCtD
Brinzolamide—Photophobia—Varenicline—nicotine dependence	0.0109	0.0147	CcSEcCtD
Brinzolamide—Dry eye—Varenicline—nicotine dependence	0.0107	0.0144	CcSEcCtD
Brinzolamide—Oesophagitis—Varenicline—nicotine dependence	0.0106	0.0143	CcSEcCtD
Brinzolamide—Hypertonia—Varenicline—nicotine dependence	0.0101	0.0137	CcSEcCtD
Brinzolamide—CA14—brain—nicotine dependence	0.00987	0.038	CbGeAlD
Brinzolamide—CA4—cardiovascular system—nicotine dependence	0.00971	0.0374	CbGeAlD
Brinzolamide—Eye pain—Varenicline—nicotine dependence	0.0093	0.0126	CcSEcCtD
Brinzolamide—Libido decreased—Varenicline—nicotine dependence	0.00906	0.0122	CcSEcCtD
Brinzolamide—Amnesia—Varenicline—nicotine dependence	0.00894	0.0121	CcSEcCtD
Brinzolamide—Visual disturbance—Varenicline—nicotine dependence	0.00886	0.012	CcSEcCtD
Brinzolamide—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00833	0.0113	CcSEcCtD
Brinzolamide—CA2—cardiovascular system—nicotine dependence	0.00805	0.031	CbGeAlD
Brinzolamide—Irritability—Varenicline—nicotine dependence	0.00801	0.0108	CcSEcCtD
Brinzolamide—Liver function test abnormal—Varenicline—nicotine dependence	0.00775	0.0105	CcSEcCtD
Brinzolamide—CA12—brain—nicotine dependence	0.0077	0.0296	CbGeAlD
Brinzolamide—Abdominal pain upper—Varenicline—nicotine dependence	0.00767	0.0104	CcSEcCtD
Brinzolamide—Breast disorder—Varenicline—nicotine dependence	0.00759	0.0103	CcSEcCtD
Brinzolamide—CA4—midbrain—nicotine dependence	0.00758	0.0292	CbGeAlD
Brinzolamide—Nasopharyngitis—Varenicline—nicotine dependence	0.00751	0.0101	CcSEcCtD
Brinzolamide—Asthma—Varenicline—nicotine dependence	0.00726	0.00981	CcSEcCtD
Brinzolamide—Angina pectoris—Varenicline—nicotine dependence	0.00707	0.00955	CcSEcCtD
Brinzolamide—Bronchitis—Varenicline—nicotine dependence	0.00698	0.00943	CcSEcCtD
Brinzolamide—Abdominal discomfort—Varenicline—nicotine dependence	0.00696	0.0094	CcSEcCtD
Brinzolamide—CA5B—brain—nicotine dependence	0.0069	0.0266	CbGeAlD
Brinzolamide—Pollakiuria—Varenicline—nicotine dependence	0.0067	0.00906	CcSEcCtD
Brinzolamide—Erectile dysfunction—Varenicline—nicotine dependence	0.00668	0.00903	CcSEcCtD
Brinzolamide—Infestation—Varenicline—nicotine dependence	0.00647	0.00874	CcSEcCtD
Brinzolamide—Infestation NOS—Varenicline—nicotine dependence	0.00647	0.00874	CcSEcCtD
Brinzolamide—Depression—Varenicline—nicotine dependence	0.00645	0.00872	CcSEcCtD
Brinzolamide—Conjunctivitis—Varenicline—nicotine dependence	0.00629	0.0085	CcSEcCtD
Brinzolamide—CA2—midbrain—nicotine dependence	0.00629	0.0242	CbGeAlD
Brinzolamide—Hepatobiliary disease—Varenicline—nicotine dependence	0.00612	0.00827	CcSEcCtD
Brinzolamide—Epistaxis—Varenicline—nicotine dependence	0.0061	0.00825	CcSEcCtD
Brinzolamide—CA1—brain—nicotine dependence	0.0061	0.0235	CbGeAlD
Brinzolamide—Sinusitis—Varenicline—nicotine dependence	0.00607	0.0082	CcSEcCtD
Brinzolamide—Bradycardia—Varenicline—nicotine dependence	0.00591	0.00799	CcSEcCtD
Brinzolamide—Hypoaesthesia—Varenicline—nicotine dependence	0.00578	0.00781	CcSEcCtD
Brinzolamide—Urinary tract disorder—Varenicline—nicotine dependence	0.00574	0.00775	CcSEcCtD
Brinzolamide—Oedema peripheral—Varenicline—nicotine dependence	0.00572	0.00773	CcSEcCtD
Brinzolamide—Connective tissue disorder—Varenicline—nicotine dependence	0.00571	0.00771	CcSEcCtD
Brinzolamide—Urethral disorder—Varenicline—nicotine dependence	0.00569	0.00769	CcSEcCtD
Brinzolamide—Visual impairment—Varenicline—nicotine dependence	0.0056	0.00756	CcSEcCtD
Brinzolamide—Eye disorder—Varenicline—nicotine dependence	0.00543	0.00733	CcSEcCtD
Brinzolamide—Tinnitus—Varenicline—nicotine dependence	0.00542	0.00732	CcSEcCtD
Brinzolamide—Cardiac disorder—Varenicline—nicotine dependence	0.00539	0.00728	CcSEcCtD
Brinzolamide—Angiopathy—Varenicline—nicotine dependence	0.00527	0.00712	CcSEcCtD
Brinzolamide—Immune system disorder—Varenicline—nicotine dependence	0.00525	0.00709	CcSEcCtD
Brinzolamide—Mediastinal disorder—Varenicline—nicotine dependence	0.00524	0.00707	CcSEcCtD
Brinzolamide—Arrhythmia—Varenicline—nicotine dependence	0.00519	0.00701	CcSEcCtD
Brinzolamide—Mental disorder—Varenicline—nicotine dependence	0.00509	0.00688	CcSEcCtD
Brinzolamide—Erythema—Varenicline—nicotine dependence	0.00506	0.00683	CcSEcCtD
Brinzolamide—Malnutrition—Varenicline—nicotine dependence	0.00506	0.00683	CcSEcCtD
Brinzolamide—Flatulence—Varenicline—nicotine dependence	0.00498	0.00673	CcSEcCtD
Brinzolamide—Dysgeusia—Varenicline—nicotine dependence	0.00495	0.00669	CcSEcCtD
Brinzolamide—Back pain—Varenicline—nicotine dependence	0.00489	0.00661	CcSEcCtD
Brinzolamide—Muscle spasms—Varenicline—nicotine dependence	0.00486	0.00657	CcSEcCtD
Brinzolamide—CA4—brain—nicotine dependence	0.00477	0.0183	CbGeAlD
Brinzolamide—Vision blurred—Varenicline—nicotine dependence	0.00477	0.00644	CcSEcCtD
Brinzolamide—Tremor—Varenicline—nicotine dependence	0.00474	0.0064	CcSEcCtD
Brinzolamide—Ill-defined disorder—Varenicline—nicotine dependence	0.00469	0.00634	CcSEcCtD
Brinzolamide—Agitation—Varenicline—nicotine dependence	0.00465	0.00628	CcSEcCtD
Brinzolamide—Malaise—Varenicline—nicotine dependence	0.00456	0.00616	CcSEcCtD
Brinzolamide—Vertigo—Varenicline—nicotine dependence	0.00454	0.00614	CcSEcCtD
Brinzolamide—Palpitations—Varenicline—nicotine dependence	0.00447	0.00604	CcSEcCtD
Brinzolamide—Cough—Varenicline—nicotine dependence	0.00441	0.00596	CcSEcCtD
Brinzolamide—Hypertension—Varenicline—nicotine dependence	0.00437	0.0059	CcSEcCtD
Brinzolamide—Arthralgia—Varenicline—nicotine dependence	0.00431	0.00582	CcSEcCtD
Brinzolamide—Chest pain—Varenicline—nicotine dependence	0.00431	0.00582	CcSEcCtD
Brinzolamide—Myalgia—Varenicline—nicotine dependence	0.00431	0.00582	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00428	0.00578	CcSEcCtD
Brinzolamide—Discomfort—Varenicline—nicotine dependence	0.00425	0.00575	CcSEcCtD
Brinzolamide—Dry mouth—Varenicline—nicotine dependence	0.00421	0.00569	CcSEcCtD
Brinzolamide—Infection—Varenicline—nicotine dependence	0.0041	0.00554	CcSEcCtD
Brinzolamide—Nervous system disorder—Varenicline—nicotine dependence	0.00405	0.00547	CcSEcCtD
Brinzolamide—Tachycardia—Varenicline—nicotine dependence	0.00403	0.00544	CcSEcCtD
Brinzolamide—Skin disorder—Varenicline—nicotine dependence	0.00401	0.00542	CcSEcCtD
Brinzolamide—CA2—brain—nicotine dependence	0.00395	0.0152	CbGeAlD
Brinzolamide—Hypotension—Varenicline—nicotine dependence	0.00386	0.00521	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00376	0.00508	CcSEcCtD
Brinzolamide—Insomnia—Varenicline—nicotine dependence	0.00373	0.00504	CcSEcCtD
Brinzolamide—Dyspnoea—Varenicline—nicotine dependence	0.00368	0.00497	CcSEcCtD
Brinzolamide—Somnolence—Varenicline—nicotine dependence	0.00367	0.00496	CcSEcCtD
Brinzolamide—Dyspepsia—Varenicline—nicotine dependence	0.00363	0.00491	CcSEcCtD
Brinzolamide—Decreased appetite—Varenicline—nicotine dependence	0.00359	0.00485	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00356	0.00481	CcSEcCtD
Brinzolamide—Fatigue—Varenicline—nicotine dependence	0.00356	0.00481	CcSEcCtD
Brinzolamide—Pain—Varenicline—nicotine dependence	0.00353	0.00477	CcSEcCtD
Brinzolamide—Feeling abnormal—Varenicline—nicotine dependence	0.0034	0.00459	CcSEcCtD
Brinzolamide—Urticaria—Varenicline—nicotine dependence	0.00328	0.00443	CcSEcCtD
Brinzolamide—Hypersensitivity—Varenicline—nicotine dependence	0.00304	0.00411	CcSEcCtD
Brinzolamide—Asthenia—Varenicline—nicotine dependence	0.00296	0.004	CcSEcCtD
Brinzolamide—Pruritus—Varenicline—nicotine dependence	0.00292	0.00395	CcSEcCtD
Brinzolamide—Diarrhoea—Varenicline—nicotine dependence	0.00282	0.00382	CcSEcCtD
Brinzolamide—Dizziness—Varenicline—nicotine dependence	0.00273	0.00369	CcSEcCtD
Brinzolamide—Vomiting—Varenicline—nicotine dependence	0.00262	0.00355	CcSEcCtD
Brinzolamide—Rash—Varenicline—nicotine dependence	0.0026	0.00352	CcSEcCtD
Brinzolamide—Dermatitis—Varenicline—nicotine dependence	0.0026	0.00351	CcSEcCtD
Brinzolamide—Headache—Varenicline—nicotine dependence	0.00259	0.00349	CcSEcCtD
Brinzolamide—Nausea—Varenicline—nicotine dependence	0.00245	0.00331	CcSEcCtD
